|
AQR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54870000002028E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10070000003404E-06 |
| Normal-vs-Stage2 |
5.259700E-03 |
| Normal-vs-Stage3 |
2.228100E-02 |
| Normal-vs-Stage4 |
2.035400E-03 |
| Stage1-vs-Stage2 |
6.097600E-01 |
| Stage1-vs-Stage3 |
3.610800E-01 |
| Stage1-vs-Stage4 |
8.704800E-01 |
| Stage2-vs-Stage3 |
7.890000E-01 |
| Stage2-vs-Stage4 |
5.743000E-01 |
| Stage3-vs-Stage4 |
4.649800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.09039999995897E-06 |
| Normal-vs-AfricanAmerican |
7.69470000000494E-05 |
| Normal-vs-Asian |
3.872600E-01 |
| Caucasian-vs-AfricanAmerican |
9.947400E-01 |
| Caucasian-vs-Asian |
6.352400E-01 |
| AfricanAmerican-vs-Asian |
6.234000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01540000244194E-08 |
| Normal-vs-Female |
2.220200E-01 |
| Male-vs-Female |
2.363100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.742010E-03 |
| Normal-vs-Extreme_Weight |
6.10899999475834E-08 |
| Normal-vs-Obese |
6.386300E-04 |
| Normal-vs-Extreme_Obese |
1.410720E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.914590E-01 |
| Normal_Weight-vs-Obese |
8.419600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.603000E-01 |
| Extreme_Weight-vs-Obese |
8.455800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.122400E-01 |
| Obese-vs-Extreme_Obese |
2.660000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.880640E-01 |
| Normal-vs-Age(41-60Yrs) |
4.225600E-04 |
| Normal-vs-Age(61-80Yrs) |
7.02560000176433E-08 |
| Normal-vs-Age(81-100Yrs) |
5.355900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.442800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.336980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.359400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.576200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.885600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.53869999466971E-08 |
| Normal-VS-Type2 PRCC |
6.247000E-04 |
| Normal-VS-KIRP CIMP |
5.062000E-01 |
| Normal-VS-Unclassified PRCC |
4.083800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.094000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.740300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.289800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.327600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.890800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.515800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.50290000000552E-07 |
| Normal-vs-N1 |
9.136400E-02 |
| Normal-vs-N2 |
1.154110E-02 |
| N0-vs-N1 |
8.728100E-02 |
| N0-vs-N2 |
8.919200E-01 |
| N1-vs-N2 |
4.128000E-01 |
|
|
